OA07978A - Compos. pharmac. constituée à titre de principe actif, par la 9a,11B-dichloro 16a-méthyl 21-oxycarbonyldicyclohexyl méthyloxy pregna-1,4-diène 3,20-dione et par un excip. pharmac. inerte apte a permettre l'action du produit dans le rectum ou le colon. - Google Patents

Compos. pharmac. constituée à titre de principe actif, par la 9a,11B-dichloro 16a-méthyl 21-oxycarbonyldicyclohexyl méthyloxy pregna-1,4-diène 3,20-dione et par un excip. pharmac. inerte apte a permettre l'action du produit dans le rectum ou le colon.

Info

Publication number
OA07978A
OA07978A OA58554A OA58554A OA07978A OA 07978 A OA07978 A OA 07978A OA 58554 A OA58554 A OA 58554A OA 58554 A OA58554 A OA 58554A OA 07978 A OA07978 A OA 07978A
Authority
OA
OAPI
Prior art keywords
pharmac
rectum
colon
dione
dichloro
Prior art date
Application number
OA58554A
Other languages
English (en)
French (fr)
Inventor
Francoise Delavallee
Roger Deraedt
Simone Jouquey
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of OA07978A publication Critical patent/OA07978A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
OA58554A 1984-04-03 1985-04-03 Compos. pharmac. constituée à titre de principe actif, par la 9a,11B-dichloro 16a-méthyl 21-oxycarbonyldicyclohexyl méthyloxy pregna-1,4-diène 3,20-dione et par un excip. pharmac. inerte apte a permettre l'action du produit dans le rectum ou le colon. OA07978A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8405222A FR2561919B1 (fr) 1984-04-03 1984-04-03 Composition pharmaceutique constituee d'une part, a titre de principe actif, par la 9a,11b-dichloro 16a-methyl 21-oxycarbonyldicyclohexyl methyloxy pregna-1,4-diene 3,20-dione et d'autre part, par un excipient pharmaceutique inerte apte a permettre l'action du produit dans le rectum ou le colon

Publications (1)

Publication Number Publication Date
OA07978A true OA07978A (fr) 1987-01-31

Family

ID=9302777

Family Applications (1)

Application Number Title Priority Date Filing Date
OA58554A OA07978A (fr) 1984-04-03 1985-04-03 Compos. pharmac. constituée à titre de principe actif, par la 9a,11B-dichloro 16a-méthyl 21-oxycarbonyldicyclohexyl méthyloxy pregna-1,4-diène 3,20-dione et par un excip. pharmac. inerte apte a permettre l'action du produit dans le rectum ou le colon.

Country Status (16)

Country Link
US (1) US4614736A (da)
EP (1) EP0161144B1 (da)
JP (1) JPS60224615A (da)
AT (1) ATE41604T1 (da)
AU (1) AU571073B2 (da)
CA (1) CA1226817A (da)
DE (1) DE3568944D1 (da)
DK (1) DK164478C (da)
FR (1) FR2561919B1 (da)
GR (1) GR850815B (da)
HU (1) HU196122B (da)
IL (1) IL74642A (da)
MA (1) MA20388A1 (da)
OA (1) OA07978A (da)
PT (1) PT80214B (da)
ZA (1) ZA851927B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8909559D0 (en) * 1989-04-26 1989-06-14 Smith Kline French Lab Pharmaceutical compositions
US5578576A (en) * 1994-09-02 1996-11-26 Dalhousie University Method and composition for treating intestinal wounds or ulcers
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
US7135455B2 (en) * 2004-11-15 2006-11-14 Allergan, Inc Methods for the therapeutic use of cyclosporine components
US7151085B2 (en) * 2004-11-15 2006-12-19 Allergan, Inc. Therapeutic methods using cyclosporine components

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2462443A1 (fr) * 1979-07-26 1981-02-13 Roussel Uclaf Nouveau derive halogene de la serie du 16a-methyl pregnane, son procede de preparation et son application comme medicament
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
FR2533928A1 (fr) * 1982-10-05 1984-04-06 Roussel Uclaf Nouveaux derives dichlores de la serie du 16a-methyl pregnane, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
IL74642A (en) 1988-09-30
HU196122B (en) 1988-10-28
DK164478B (da) 1992-07-06
ATE41604T1 (de) 1989-04-15
DK146785D0 (da) 1985-04-01
FR2561919A1 (fr) 1985-10-04
AU571073B2 (en) 1988-03-31
IL74642A0 (en) 1985-06-30
FR2561919B1 (fr) 1986-12-19
EP0161144A1 (fr) 1985-11-13
DK146785A (da) 1985-10-04
DE3568944D1 (en) 1989-04-27
AU4080085A (en) 1985-10-10
PT80214A (en) 1985-05-01
DK164478C (da) 1992-11-23
JPS60224615A (ja) 1985-11-09
HUT44436A (en) 1988-03-28
CA1226817A (fr) 1987-09-15
GR850815B (da) 1985-07-23
EP0161144B1 (fr) 1989-03-22
US4614736A (en) 1986-09-30
PT80214B (en) 1987-02-17
MA20388A1 (fr) 1985-10-01
ZA851927B (en) 1986-04-30

Similar Documents

Publication Publication Date Title
GEP20022656B (en) 2-(Purin-9-YL)-Tetrahydrofuran-3,4-Diol Derivatives
AU554443B2 (en) 4-aminosalicylic acid as an anti-inflammatory agent
IE780643L (en) THERAPEUTIC APPLICATION OF d, 1-CARNITINE DERIVITIVES
ES2059965T3 (es) Un procedimiento para preparar una composicion farmaceutica para el tratamiento de enfermedades inflamatorias.
DE59108854D1 (de) Arzneimittel sowie deren herstellung und deren verwendung bei der bekämpfung von schmerzen und/oder entzündungen an tieren und menschen
ATE62414T1 (de) Mittel zur behandlung von herzerkrankungen.
RU93005355A (ru) Фармакологические композиции
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
IT8009551A0 (it) E-5-(2-alogenovinil-)-2'deossicitidine, loro metodo di preparazione e loro impiego per il trattamentodi malattie da virus
FR2403800A1 (fr) Composition de traitement de la peau a activite antivirale
OA07978A (fr) Compos. pharmac. constituée à titre de principe actif, par la 9a,11B-dichloro 16a-méthyl 21-oxycarbonyldicyclohexyl méthyloxy pregna-1,4-diène 3,20-dione et par un excip. pharmac. inerte apte a permettre l'action du produit dans le rectum ou le colon.
AU5323396A (en) Methods of treating inflammation and compositions therefor
EP0334853A4 (en) LIGHT STEROIDS WITH ANTI-INFLAMMATORY ACTIVITY.
ES8304058A1 (es) Un procedimiento para la preparacion del acido 3,7,11,15-tetrametil-2,4,6,10,14-hexadecapentaenoico.
RU93048868A (ru) Способ безопасного введения жирных кислот, его применение для лечения рака, инфекционных вирусных заболеваний и других нарушений
DE551180T1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
ATE86611T1 (de) Topische vorstufen von arzneimitteln zur behandlung von akne und hautkrankheiten.
DE3674323D1 (de) 4-methoxyisophthalsaeurederivat mit pharmakologischer wirksamkeit gegen thromboembolische erkrankung und verfahren zu dessen herstellung.
胡亚美 et al. STUDIES OF QINGYANGSHEN (ROOT OF CYNANCHUM OTOPHYLLUM) Ⅰ. EFFECT CF QINGYANGSHEN ON COPPER AND ZINC METABOLISM
Maeda Studies on relations of temperature of topically used cortico-steroid hormone (beta-methasone) to its therapeutic effect Part I. Clinical investigation on acute otitis media cases
RU94024641A (ru) Способ лечения противовоспалительных процессов
ES530605A0 (es) Procedimiento para fabricar compuestos piperidinonicos eficaces en el tratamiento de cardiopatias
ZA855340B (en) Use of o-substituted pyruvic acid oximes for the prophylaxis and/or treatment of heart and circulatory diseases,as well as corresponding medicaments
RU94002713A (ru) Способ лечения детей с синдромом удлиненного интервала qт (романо-уорда)
ATE75617T1 (de) Behandlung gewebedegenerativer entzuendungskrankheiten.